Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis

Digestive and Liver Disease

Volumn 35, Issue 7, 2003, Pages 473-478

  Thompoulos, K C ^a   Labropoulou Karatza, C ^a   Mimidis, K P ^b   Katsakoulis, E C ^a   Iconomou, G ^a   Nikolopoulou, V N ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cirrhosis; Varices

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; VASOACTIVE AGENT;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; ASCITES; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE MARKER; DISEASE SEVERITY; ESOPHAGOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; PREDICTION; PREVALENCE; SPLEEN SIZE; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; BLOOD; MIDDLE AGED; PREDICTION AND FORECASTING;

ASCITES; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; SPLENOMEGALY; THROMBOCYTOPENIA;

EID: 0242368098     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00219-6     Document Type: Article

References (30)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
2. Pagliaro L, D'Amico G, Pasta L, et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann RJ, editors, Portal hypertension: pathophysiology and treatment, Oxford: Blackwell Scientific, 1994, pp. 72-92.
3. Colombo E, Casiraghi MA, Minoli G, Prada A, Terruzzi V, Bortoli A, et al. First bleeding episode from oesophageal varices in cirrhotic patients: a prospective study of endoscopic predictive factors. Ital J Gastroenterol 1995;27:345-8.
4. Ricca Rosellini S, Miglio F. Beta-blockers for the prevention of variceal haemorrhage in patients with cirrhosis: an updated meta-analysis of randomized controlled trials. Ital J Gastroenterol 1991;23:408-15.
5. Poynard T, Gales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, et al. Beta-adrenergic antagonist drugs in the prevention of first gastrointestinal bleeding in patients with cirrhosis, and esophageal varices. New Engl J Med 1991;324:1532-8.
6. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.
7. Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long term survival in cirrhosis. Gastroenterology 1997;113:1632-9.
8. Lay CS, Tsai YT, Teg Cy Shyu WS, Guo WS, Wu KL, Lo KJ. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997;25:1346-50.
9. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2000;46(Suppl III):1-15.
10. Grace N. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081-91.
11. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
12. De Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson JM, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus development workshop. J Hepatol 1992;15:256-61.
13. Burroughs AK. The natural history of varices. J Hepatol 1993;17:S10-3.
14. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices and risk of gastrointestinal bleeding in patients with alcoholic cirrhosis. Gastroenterology 1980;79:1139-44.
15. The North Italian Endoscopic Club for the study and treatment of esophageal varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. New Engl J Med 1988;319:983-9.
16. Cales P, Oberti F, Payen JN, Naveau S, Guyader D, Blanc P, et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol 1999;11:741-5.
17. Zaman A, Hapke R, Flora K, Rosen HR, et al. Factors predicting the presence of esophageal and gastric varices in patients with advanced liver disease. Hepatology 1997;26:A29.
18. Barcia HX, Robalina GA, Molina EG, et al. Clinical predictors of large varices in cirrhotic patients. Gastrointest Endosc 1998;47:A78.
19. Chalasani N, Imperial TF, Ismail A, Sood G, Carey M, Wileox CM. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999;94:3286-91.
20. Lavergne J, Molina E, Reddy KR, Jeffers L, Leon R, Nader AK, et al. Ascites predicts the presence of high grade varices by screening gastroscopy. Gastrointest Endosc 1997;45:AB187.
21. Alarcon F, Burke CA, Larive NB. Esophageal varices in patients with cirrhosis: is screening endoscopy necessary for everyone? Am J Gastroenterol 1998;93:255.
22. Amarapurkar DN, Parikh SS, Shankaran K, Chopra K, Dhawan P, Karlo RH, et al. Correlation between splenomegaly and oesophageal varices in patients with liver cirrhosis. Endoscopy 1994;26:563.
23. Garcia-Tsao G, Escorsell A, Zakko M, Patch D, Matloff D, Grace N. Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients. Hepatology 1997;26:360A.
24. Cales P, Desmorat H, Vinel JP, Caucanas JP, Ravaud A, Gerin P, et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 1990;31(11):1298-302.
25. Zaman A, Hapke R, Flora K, Rosen HR, Bennet K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999;94:3292-6.
26. Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999;3:867-73.
27. Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection. Hepatology 2001;33:333-8.
28. Bolondi L, Zironi G, Gaiani S, Li Bassi S, Benzi G, Barbara L. Caliber of splenic and hepatic arteries and spleen size in cirrhosis of different etiology. Liver 1991;11:198-205.
29. Aiello A, Calapristi I, Freni MA, Fava A, Scarpignato EM, Spadaro A, et al. Assessment of portal hypertension in hepatic cirrhosis in relation to etiologic factors. Minerva Gastroenterol Dietol 1993;39:1-5.
30. Goulis J, Chau TN, Jordan S, Mehta AB,Watkinson A, Rolles K, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999;44:754-8.